NEMTABRUTINIB: 11 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
11
Total FAERS Reports
0
Deaths Reported
0
Hospitalizations
11
As Primary/Secondary Suspect
1
Life-Threatening
First Report: 20240506 · Latest Report: 20240506
What Are the Most Common NEMTABRUTINIB Side Effects?
#1 Most Reported
Thrombocytopenia
10 reports (90.9%)
#2 Most Reported
Disease progression
8 reports (72.7%)
#3 Most Reported
Splenomegaly
7 reports (63.6%)
All NEMTABRUTINIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Thrombocytopenia | 10 | 90.9% | 0 | 0 |
| Disease progression | 8 | 72.7% | 0 | 0 |
| Acetabulum fracture | 7 | 63.6% | 0 | 0 |
| Anaphylactic shock | 7 | 63.6% | 0 | 0 |
| Leukopenia | 7 | 63.6% | 0 | 0 |
| Neutropenia | 7 | 63.6% | 0 | 0 |
| Splenomegaly | 7 | 63.6% | 0 | 0 |
Who Reports NEMTABRUTINIB Side Effects? Age & Gender Data
Gender: 0.0% female, 100.0% male. Average age: 48.6 years. Most reports from: PL. View detailed demographics →
Is NEMTABRUTINIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2024 | 7 | 0 | 0 |
What Is NEMTABRUTINIB Used For?
| Indication | Reports |
|---|---|
| Follicular lymphoma | 10 |
Official FDA Label for NEMTABRUTINIB
Official prescribing information from the FDA-approved drug label.